Monitoring Your Heart via the Internet - WSJ.com

Is American medicine ready for a device that's surgically implanted, costs thousands of dollars -- but delivers absolutely no therapy? That question will be on the table tomorrow when a Food and Drug Administration advisory panel considers whether the FDA should approve one of the first of a coming wave of implantable sensors now being developed. Specifically, the agency is set to review a diagnostic-only device called the Chronicle from Medtronic Inc. that would be used by very sick patients with heart failure, in hopes of keeping them out of the emergency room.